Science
I received the largest dose of psilocybin ever administered in a published FDA study. Dose #1
A 3-part series on one participant's high dose psilocybin experience in the Pharmacokinetics of Psilocybin in Normal Adult Volunteers study at the University of Wisconsin.
Precautions with Underground Psychedelic Therapy
In underground sessions, you’re taking a huge risk choosing to work with someone who may not have adequately prepared or may have dubious subconscious motivations.
Do psychedelics trigger neurogenesis? Here’s what we know.
What is neurogenesis? Do psychedelics really cause it? If they do, what doors might that open up?
Non-PTSD Uses for MDMA
While much progress has been made, a narrow focus of MDMA just for PTSD obscures the larger applications of MDMA, particularly for those whom traditional psychotherapy has been largely ineffective.
How Does LSD Induce Short-Term Psychosis but Long-Term Optimism?
There’s only one way to find out – more scientific experiments.
Finding The Sweet Spot: At 62 I Had My First Dose Of Psilocybin At Johns Hopkins
A research program was seeking volunteers with a spiritual background to ingest a hallucinogen.
Winter Blues Got You Down? Try These Integrative Antidepressant Approaches
Here's some integrative antidepressant approaches that have low or no side effects and won't cost you an arm and a leg.
My First Psychedelic Experience at Johns Hopkins Changed My Life
It’s been more than six years since I participated in the Johns Hopkins Spirituality study, but it continues as the most life-changing event of my life.
Psychedelic Frontiers of Western Medicine
Johns Hopkins and Yale Schools of Medicine reviewed dozens of studies and recent trials on psychedelic compounds.
A Divine Encounter In The Johns Hopkins Psilocybin Study
"On Tuesday, you will be the only person in the U.S. who will be taking psilocybin legally.”
We Talked with World Ayahuasca Conference Organizer Ben De Loenen
"Too many people just see ayahuasca as a sales product and that’s a problem, where it becomes commodified."
Canada Approves Legal Heroin For Severely Addicted Patients
Canada has amended its policies on heroin to allow doctors to prescribe the drug to patients suffering severe addiction.
Dorion Sagan on Carl Sagan, Lynn Margulis, and his new book, Cracking the Aging Code
In this interview I talk with Dorion Sagan about whether his father Carl Sagan used LSD, his mother Lynn Margulis’s paradigm-changing theory of symbiogenesis, her thoughts on psychedelics, and his new book Cracking the Aging Code: The New Science of Growing Old-And What It Means for Staying Young.
Comedian Adam Strauss on treating OCD with psilocybin mushrooms
Inspired by a scientific study showing that psilocybin mushrooms can potentially cure OCD, Adam Strauss embarked on vigilante psychopharmacology.
Patterning a World of Mushrooms: The Challenges of Co-Production
‘Co-production’ refers to processes in which a range of experts and non-experts are enrolled as researchers and attempt to generate knowledge together.
Science
I received the largest dose of psilocybin ever administered in a published FDA study. Dose #1
A 3-part series on one participant's high dose psilocybin experience in the Pharmacokinetics of Psilocybin in Normal Adult Volunteers study at the University of Wisconsin.
Precautions with Underground Psychedelic Therapy
In underground sessions, you’re taking a huge risk choosing to work with someone who may not have adequately prepared or may have dubious subconscious motivations.
Do psychedelics trigger neurogenesis? Here’s what we know.
What is neurogenesis? Do psychedelics really cause it? If they do, what doors might that open up?
Non-PTSD Uses for MDMA
While much progress has been made, a narrow focus of MDMA just for PTSD obscures the larger applications of MDMA, particularly for those whom traditional psychotherapy has been largely ineffective.
How Does LSD Induce Short-Term Psychosis but Long-Term Optimism?
There’s only one way to find out – more scientific experiments.
Finding The Sweet Spot: At 62 I Had My First Dose Of Psilocybin At Johns Hopkins
A research program was seeking volunteers with a spiritual background to ingest a hallucinogen.
Winter Blues Got You Down? Try These Integrative Antidepressant Approaches
Here's some integrative antidepressant approaches that have low or no side effects and won't cost you an arm and a leg.
My First Psychedelic Experience at Johns Hopkins Changed My Life
It’s been more than six years since I participated in the Johns Hopkins Spirituality study, but it continues as the most life-changing event of my life.
Psychedelic Frontiers of Western Medicine
Johns Hopkins and Yale Schools of Medicine reviewed dozens of studies and recent trials on psychedelic compounds.
A Divine Encounter In The Johns Hopkins Psilocybin Study
"On Tuesday, you will be the only person in the U.S. who will be taking psilocybin legally.”
We Talked with World Ayahuasca Conference Organizer Ben De Loenen
"Too many people just see ayahuasca as a sales product and that’s a problem, where it becomes commodified."
Canada Approves Legal Heroin For Severely Addicted Patients
Canada has amended its policies on heroin to allow doctors to prescribe the drug to patients suffering severe addiction.
Dorion Sagan on Carl Sagan, Lynn Margulis, and his new book, Cracking the Aging Code
In this interview I talk with Dorion Sagan about whether his father Carl Sagan used LSD, his mother Lynn Margulis’s paradigm-changing theory of symbiogenesis, her thoughts on psychedelics, and his new book Cracking the Aging Code: The New Science of Growing Old-And What It Means for Staying Young.
Comedian Adam Strauss on treating OCD with psilocybin mushrooms
Inspired by a scientific study showing that psilocybin mushrooms can potentially cure OCD, Adam Strauss embarked on vigilante psychopharmacology.
Patterning a World of Mushrooms: The Challenges of Co-Production
‘Co-production’ refers to processes in which a range of experts and non-experts are enrolled as researchers and attempt to generate knowledge together.